Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03542799
What this trial is testing

EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Shenzhen Second People's Hospital 20
Early research (Phase 1)Study completedNCT02546167
What this trial is testing

CART-BCMA Cells for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 25
Not applicableTemporarily pausedNCT06310811
What this trial is testing

Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
SafetyEffective
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Early research (Phase 1)Looking for participantsNCT07350863
What this trial is testing

U69-CART-Cells For R/R T-ALL

Who this might be right for
Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University 12
Early research (Phase 1)WithdrawnNCT05950113
What this trial is testing

CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05665062
What this trial is testing

Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies

Who this might be right for
CLL/SLLNHLMantle Cell Lymphoma+4 more
Synthekine 36
Testing effectiveness (Phase 2)Looking for participantsNCT07169500
What this trial is testing

Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableLooking for participantsNCT07342179
What this trial is testing

CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)

Who this might be right for
Multiple Myeloma (MM)
Poitiers University Hospital 60
Not applicableWithdrawnNCT03492268
What this trial is testing

Safety and Efficacy Evaluation of BCMA-CART for Treating Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bioray Laboratories
Early research (Phase 1)Ended earlyNCT04142619
What this trial is testing

Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Cellectis S.A. 11
Testing effectiveness (Phase 2)Ended earlyNCT03184753
What this trial is testing

Genetically Modified T Cells Against Ovarian Cancer

Who this might be right for
Ovarian Cancer
Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT04422912
What this trial is testing

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Who this might be right for
Pemphigus Vulgaris
Cabaletta Bio 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04146051
What this trial is testing

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Who this might be right for
Myasthenia Gravis, Generalized
Cartesian Therapeutics 30
Not applicableLooking for participantsNCT06983951
What this trial is testing

Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis

Who this might be right for
Light Chain Amyloidosis
Beijing Boren Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07489534
What this trial is testing

Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction

Who this might be right for
Multiple Myeloma
Daihong Liu 25
Early research (Phase 1)Looking for participantsNCT06056102
What this trial is testing

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Who this might be right for
Kidney TransplantKidney FailureEnd Stage Renal Failure on Dialysis
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT04026737
What this trial is testing

Cardiovascular Effects of CART Cell Therapy

Who this might be right for
LeukemiaLymphomaCardiotoxicity+2 more
Abramson Cancer Center at Penn Medicine 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT05672459
What this trial is testing

A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors

Who this might be right for
Solid Tumor
M.D. Anderson Cancer Center 31
Early research (Phase 1)Ended earlyNCT05352542
What this trial is testing

GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
jianming xu 10
Not applicableLooking for participantsNCT07180992
What this trial is testing

Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma

Who this might be right for
Multiple MyelomaMonocytesCART Cells
Centre Hospitalier Universitaire, Amiens 25
Next Page